Palisade Bio (PALI) Total Current Liabilities (2010 - 2026)

Palisade Bio (PALI) has 17 years of Total Current Liabilities data on file, last reported at $5.6 million in Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $5.6 million, up 102.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.6 million (up 102.38% YoY), and the FY2025 annual result was $4.6 million, up 43.26% from the prior year.
• Total Current Liabilities grew to $5.6 million in Q1 2026 per PALI's latest filing, from $4.6 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $5.6 million in Q1 2026 and troughed at $1.3 million in Q1 2023.
• A 5-year average of $3.0 million and a median of $2.8 million in 2024 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2023 and 2026: Total Current Liabilities declined 29.45% in 2023, then soared 102.38% in 2026.
• A 5-year view of Total Current Liabilities shows it stood at $3.0 million in 2022, then slipped by 14.14% to $2.6 million in 2023, then grew by 25.14% to $3.2 million in 2024, then jumped by 43.26% to $4.6 million in 2025, then climbed by 21.23% to $5.6 million in 2026.
• Business Quant data shows PALI's Total Current Liabilities at $5.6 million in Q1 2026, $4.6 million in Q4 2025, and $3.5 million in Q3 2025.